Discover How Helix is Changing the World of Healthcare
Resources Hub
Genetic Screening for Familial Hypercholesterolemia
Top Viral Surveillance Insights: COVID positivity rises right before Thanksgiving
How to Achieve Health Equity on a Population Scale
Cone Health launches population genomics project with NIH-backed startup Helix
Helix, Cone Health Partner on 100K-Subject Population Genomics Study
Groundbreaking Insights on Actionable Genetic Associations from ASHG
Top Viral Surveillance Insights: Why there may be a ‘twindemic’ this winter
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative
The Latest Content From Helix
Recent Blog Posts
View All Blog Posts
Blog
MedCity Pivot Podcast: Precision Medicine with the CEO of Helix
Blog
Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards
Blog
Advancing Cancer Care: Helix's New DPYD Testing for Safer Chemotherapy
By MD, FACP, FACMG Cassie Hajek, Medical Director at Helix
Blog
Population Genomics: Personalizing Genetic Breast Cancer Screening
Recent Press Releases
View All Press ReleasesPress Releases
Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments
Press Releases
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Press Releases
Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward
Recent Videos
View All Videos
Recent Published Research
View All Published Research1
Published Research
Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60
2
Published Research
Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions
3
Published Research
Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia
4
Published Research
Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes
5
Published Research